CVS Health Co. (NYSE:CVS) Shares Bought by Hilltop Holdings Inc.

Hilltop Holdings Inc. raised its stake in CVS Health Co. (NYSE:CVS) by 31.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,265 shares of the pharmacy operator’s stock after buying an additional 5,286 shares during the quarter. Hilltop Holdings Inc.’s holdings in CVS Health were worth $1,400,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Chevy Chase Trust Holdings LLC increased its stake in CVS Health by 2.0% during the third quarter. Chevy Chase Trust Holdings LLC now owns 941,144 shares of the pharmacy operator’s stock worth $59,179,000 after purchasing an additional 18,734 shares during the period. Cinctive Capital Management LP purchased a new stake in CVS Health during the third quarter worth about $13,013,000. Benjamin Edwards Inc. increased its stake in CVS Health by 548.2% during the third quarter. Benjamin Edwards Inc. now owns 35,837 shares of the pharmacy operator’s stock worth $2,254,000 after purchasing an additional 30,308 shares during the period. Atom Investors LP purchased a new stake in CVS Health during the third quarter worth about $1,273,000. Finally, TOMS Capital Investment Management LP purchased a new stake in CVS Health during the third quarter worth about $121,987,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS stock opened at $59.20 on Wednesday. The company has a market capitalization of $74.50 billion, a P/E ratio of 15.03, a PEG ratio of 1.01 and a beta of 0.54. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The business has a 50 day simple moving average of $59.43 and a 200-day simple moving average of $58.80. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period last year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities analysts anticipate that CVS Health Co. will post 5.37 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.49%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio is presently 67.51%.

Wall Street Analyst Weigh In

CVS has been the topic of a number of recent research reports. Piper Sandler cut their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. UBS Group upped their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, Evercore ISI upped their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $70.50.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.